Business Context and Reporting Period
Company: Universal Display Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 17, 2012
Event Date: May 10, 2012
Subject: Developments in Legal Proceedings regarding Japanese patent invalidation trials.
Key Financial Metrics
This filing is a current report regarding legal proceedings and does not contain financial statements. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Legal Developments
The company reported two significant developments regarding Japanese patent invalidation trials previously disclosed in its Form 10-Q for the period ended March 31, 2012:
- JP '929 Patent: On May 16, 2012, the Japanese High Court confirmed the validity of certain claimed inventions but upheld the Japanese Patent Office's (JPO) decision to invalidate the broadest claims. The company plans to appeal this decision to the Japanese Supreme Court upon receipt of translated documents.
- JP '124 Patent: On May 10, 2012, the JPO issued a decision upholding the validity of certain claimed inventions but invalidating the broadest claims. The company believes this decision was erroneous and intends to appeal to the Japanese High Court.
Management Commentary and Risks
Impact Assessment: Management believes these decisions should not have a material adverse impact on the Company's global portfolio of patents, pending applications, or its ability to pursue licensing and material sales business opportunities.
Risk Factors: The filing references the "Risk Factors" section of the Annual Report on Form 10-K for the year ended December 31, 2011, noting ongoing risks related to the protection of intellectual property.
Investor Verification Checklist
- Verify the status of the appeal to the Japanese Supreme Court for the JP '929 patent.
- Monitor the outcome of the appeal to the Japanese High Court for the JP '124 patent.
- Review the "Risk Factors" section of the 2011 Form 10-K for detailed intellectual property risks.
- Confirm whether the invalidation of "broadest claims" affects specific licensing agreements or product lines.